Dr Reddys Laboratories Share Price Today - Live Blog for November 03, 2025

Demonstrating a commendable 0.01% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,196.45. In terms of valuation, the stock maintains a PE ratio of 17.4200, while the industry PE ratio stands at 34.6343.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.17% uptick in its share price. As a result, it's now actively trading at ₹1,198.15 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd witnessed a notable 0.01% surge in its share price and is presently trading at ₹1,196.15, captivating the attention of market participants.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,196.90. The stock is currently trading at a PE of 17.4200, while the industry PE is 34.6343, prompting investors to assess its value proposition.

With a -0.19% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,198.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.4200, while the industry PE is 34.6343.

The stock of Dr Reddys Laboratories Ltd suffered a -0.01% drop, and it's now trading at ₹1,200.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd experienced a -0.10% downturn in its share price, and it's currently trading at ₹1,198.90. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.10% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,198.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.4200, while the industry PE is 34.6343.

Demonstrating a commendable 0.02% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,199.85. In terms of valuation, the stock maintains a PE ratio of 17.4200, while the industry PE ratio stands at 34.6343.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,199.85 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd witnessed a -0.04% drop in its share price and is currently trading at ₹1,198.70. With the stock's PE at 17.4200 and the industry PE at 34.6343, investors are weighing their options.

Dr Reddys Laboratories Ltd shares experienced a -0.04% reduction, with the current market price at ₹1,198.70. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd plunged by -0.04%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,199.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.24% gain, with the share price now at ₹1,199.00. Notably, the stock's PE ratio stands at 17.4200, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd share price surged by 0.05%. With its current market price standing at ₹1,196.00 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.11% drop, and it's now trading at ₹1,195.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.04% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,196.90 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.13% upswing, and it's currently trading at ₹1,197.50 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd is facing a -0.13% decline and is currently trading at ₹1,196.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.14%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,198.40 per share.

Dr Reddys Laboratories Ltd's share price has dropped by -0.01%, a development that warrants careful analysis. Presently trading at ₹1,196.80, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a substantial 0.20% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,196.50, making it an appealing option for investors.

Dr Reddys Laboratories Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,194.10. The stock has a PE ratio of 17.4200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced a -0.07% slump and is currently trading at ₹1,196.00. While the stock maintains a PE ratio of 17.4200, the industry PE is 34.6343, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has dropped by -0.03%, a development that warrants careful analysis. Presently trading at ₹1,196.80, investors are assessing whether this presents an opportunity or a risk.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.15%, reaching the current market price of ₹1,192.00. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares experienced a -1.21% reduction, with the current market price at ₹1,189.30. Investors are carefully considering their positions and seeking insights into the stock's future performance.